Lilly licenses sintilimab from Suzhou-based biotech Innovent Biologics ... and Dr Jill Biden. Eli Lilly has unveiled a $2.5 billion deal to acquire rights to a breast cancer therapy being ...
GlobalData on MSN4mon
EASD 2024: Innovent shows off mazdutide’s efficacy in diabetes and obesityThe Suzhou, China-based biotech has presented ... which showed mazdutide to be superior to Eli Lilly’s Trulicity (dulaglutide ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback